title: [Sublingual immunotherapy. Where are we now?].
abstract: Allergic diseases represent a global health problem. They affect 20% to 30% of the German population, but more than 40% of the group between 20 and 40 years of age. The symptoms have a considerable influence on social life and cause an impairment of sleep and performance at work/school, leading to a high but avoidable economic impact. For over 100 years specific immunotherapy (SIT) has been used to treat IgE-mediated allergic diseases. Numerous well-controlled studies have provided evidence of its efficacy, safety and tolerability. Today SIT represents a well-established treatment of allergic rhinitis, rhinoconjunctivitis and allergic asthma with a positive health economic impact. Initially, SIT was administered subcutaneously (SCIT), but other routes of application have been developed. In particular the sublingual-swallow method (SLIT) has been proven to be effective and well-tolerated in large studies on grass pollen allergies and represents an additional effective route of administration in adults and children.
authors: Allergie-Centrum-Charité, Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin Berlin, Berlin.
authors: H
authors: H
authors: Lee
authors: T
authors: T
authors: Zuberbier
authors: M
authors: M
authors: Worm
references: Pediatr Allergy Immunol. 2007 Feb;18(1):58-62
references: 17295800
references: J Allergy Clin Immunol. 2004 Jun;113(6):1025-34; quiz 1035
references: 15208578
references: J Allergy Clin Immunol. 2006 May;117(5):1021-35
references: 16675328
references: Allergy. 2009 Nov;64(11):1570-9
references: 19796205
references: Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009;96:87-95; discussion 95
references: 20799448
references: Respir Med. 2006 Aug;100(8):1374-83
references: 16403616
references: Allergy. 2007 May;62(5):567-8
references: 17313400
references: J Allergy Clin Immunol. 2006 Apr;117(4):802-9
references: 16630937
references: Allergy. 2009 Jun;64(6):849-54
references: 19392995
references: Allergy. 2007 Jul;62(7):810-7
references: 17573730
references: Allergy. 2009 Oct;64(10):1486-92
references: 19385952
references: Allergy. 2004 May;59(5):498-504
references: 15080830
references: Curr Opin Allergy Clin Immunol. 2009 Dec;9(6):544-8
references: 19823080
references: Int Arch Allergy Immunol. 2011;154(4):336-44
references: 20975285
references: Eur Ann Allergy Clin Immunol. 2006 Dec;38(10):355-60
references: 17274520
references: Vaccine. 2010 Apr 9;28(17):2986-92
references: 20175969
references: J Allergy Clin Immunol. 2009 Jan;123(1):167-173.e7
references: 19130937
references: J Allergy Clin Immunol. 2011 Jan;127(1):18-27; quiz 28-9
references: 21211639
references: Allergy. 2006 Oct;61(10):1177-83
references: 16942565
references: Clin Exp Allergy. 2010 Apr;40(4):598-606
references: 20184605
references: Cochrane Database Syst Rev. 2010 Dec 08;(12):CD002893
references: 21154351
references: J Allergy Clin Immunol. 2009 Jan;123(1):160-166.e3
references: 19046761
references: Pediatr Allergy Immunol. 2010 Jun;21(4 Pt 1):559-63
references: 20636895
references: J Allergy Clin Immunol. 2008 Feb;121(2):368-374.e1
references: 18036651
references: Eur J Immunol. 2003 May;33(5):1205-14
references: 12731045
references: Allergy. 2006 Oct;61(10):1236-7
references: 16942577
references: J Allergy Clin Immunol. 2010 Jan;125(1):131-8.e1-7
references: 20109743
references: J Allergy Clin Immunol. 2007 Dec;120(6):1338-45
references: 17935764
references: J Allergy Clin Immunol. 2010 Mar;125(3):660-6, 666.e1-666.e4
references: 20153030